Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Banned? Oral vs. Injectable Forms Explained